SM
Sabby Management’s Inhibikase Therapeutics IKT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-99,000
| Closed | -$147K | – | 86 |
|
|
2022
Q1 | $147K | Sell |
99,000
-326,014
| -77% | -$484K | 0.02% | 64 |
|
|
2021
Q4 | $625K | Hold |
425,014
| – | – | 0.09% | 59 |
|
|
2021
Q3 | $808K | Buy |
425,014
+3,814
| +0.9% | +$7.25K | 0.11% | 52 |
|
|
2021
Q2 | $1.18M | Buy |
+421,200
| New | +$1.18M | 0.17% | 38 |
|